LYNK Pharmaceuticals

About:

LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines.

Top Investors: Legend Capital, Lilly Asia Ventures, Decheng Capital, Med-Fine Capital, Kaitai Capital

Description:

LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases. The company was founded in 2018 and is headquartered in Hangzhou, Zhejiang, China.

Total Funding Amount:

$125M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Hangzhou, Zhejiang, China

Founded Date:

2018-01-01

Contact Email:

ychen1(AT)lynkpharma.com

Founders:

Jardo Chein, Jun Wang, Michael Vazquez, Zhao-Kui Wan

Number of Employees:

11-50

Last Funding Date:

2023-09-21

IPO Status:

Private

Industries: